XR Securities’s Bausch Health BHC Stock Holding History

XR Securities’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,887	Closed	-$75.6K	–	378
2022 Q2	$91K	Buy	+10,887	New	+$152K	0.03%	227
2019 Q1	–	Sell	-11,034	Closed	-$204K	–	278
2018 Q4	$204K	Buy	11,034 +1,188	+12%	+$28.3K	0.09%	138
2018 Q3	$253K	Buy	+9,846	New	+$225K	0.07%	150

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

XR Securities's BHC Position: Q3 2022 in Review

XR Securities sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 10,887 shares — an estimated $75.6K sold.

XR Securities first reported a position in BHC in Q3 2018 and held it in 3 quarters. The position peaked at $253K in Q3 2018. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

XR Securities reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
XR Securities sold 10,887 Bausch Health shares in Q3 2022, an estimated $75.6K.
XR Securities first reported a position in Bausch Health in Q3 2018 and held it in 3 quarters.
XR Securities's Bausch Health position peaked at $253K in Q3 2018.
283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on XR Securities's 13F filing for Q3 2022, filed 18 Oct 2022.